Increasing Intensity of On-Site Monitoring a Troubling Trend
The percentage of source document verification coverage has been decreasing slightly over the past four years. Therefore, the amount of on-site time required by site monitors should also start decreasing.
Cambridge, MassachusettsDownload Brochure
-
- Risk-Based Approach to Monitoring
- Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?More in Risk-Based Monitoring
- Monitoring on-site rate—the average number of on-site monitoring days per site per year
- SDV velocity—the average number of eCRF data points SDV'd per on-site day
Monitoring rates in Phase II-III trials, 2008-2011.
Articles in this issue
about 13 years ago
Managing Budgets in Complex Times with Tight Variancesabout 13 years ago
Act coverabout 13 years ago
Business and News Update July 2012about 13 years ago
Increasing Intensity of On-Site Monitoring a Troubling Trendabout 13 years ago
Drug Information? Forget it!about 13 years ago
Supply Chain Managementabout 13 years ago
Developing Quality Biosimilarsabout 13 years ago
Drivers of Patient Interest in Referralabout 13 years ago
Risk-Based Monitoring Risky for Sponsors?about 13 years ago
Fresh Doubts Cast Over Post-Marketing Trialsabout 13 years ago
Health Reform Declared Constitutionalabout 13 years ago
Flying Blind on CRA Workload, Time Demandsabout 13 years ago
Emergency Department Setting Trialsabout 13 years ago
Applied Clinical Trials Digital Edition - July 2012Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025